首页 正文

Fenfluramine for treatment-resistant epilepsy in Dravet syndrome and other genetically mediated epilepsies

{{output}}
Fenfluramine hydrochloride, initially utilized as a weight loss drug in the 1970s and later removed from the market for adverse cardiopulmonary side effects, has since been repurposed as an antiseizure medicine (ASM). The potential antiseizure effects of fenfl... ...